A Study to Investigate the Pharmacokinetics of AZD2389 in Healthy Participants When Administered Alone and in Combination With Quinidine

NCT06974565 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Chronic Liver Disease
Healthy Participants

Interventions

DRUG: AZD2389
DRUG: Quinidine

Sponsor

AstraZeneca

Collaborators

[object Object]